Login

Wanbury Ltd.

₹260.1

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Wanbury Ltd.

  • NSE : WANBURY
Add Alert
Add Watchlist

₹260.1

₹260.1

8.15 (3.23%) - 18 Aug 2025 04:31 PM
  • NSE : WANBURY

About Company

Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. Wanbury’s major trust area lies in Active Pharmaceutical Ingredient (API) Sales & Marketing in several countries and Pan-India Formulation presence.

Market Cap. ₹ 855 Cr.
52 Week - High/Low ₹ 330/154
P/E Ratio 19.85
P/B Ratio 30.60
Enterprise Value ₹ 1,031 Cr.
ROE % 502.76
RSI Value 47.80
EMA 50 265.57
EMA 200 249.21
Market Cap. ₹ 855 Cr.
52 Week - High/Low ₹ 330/154
P/E Ratio 19.85
P/B Ratio 30.60
Enterprise Value ₹ 1,031 Cr.
ROE % N/A
RSI Value 47.80
EMA 50 265.57
EMA 200 249.21
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.